AUPR743101A0 - A cancer therapeutic - Google Patents

A cancer therapeutic

Info

Publication number
AUPR743101A0
AUPR743101A0 AUPR7431A AUPR743101A AUPR743101A0 AU PR743101 A0 AUPR743101 A0 AU PR743101A0 AU PR7431 A AUPR7431 A AU PR7431A AU PR743101 A AUPR743101 A AU PR743101A AU PR743101 A0 AUPR743101 A0 AU PR743101A0
Authority
AU
Australia
Prior art keywords
cancer therapeutic
cancer
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR7431A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intreat Pty Ltd
Original Assignee
Intreat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd filed Critical Intreat Pty Ltd
Priority to AUPR7431A priority Critical patent/AUPR743101A0/en
Publication of AUPR743101A0 publication Critical patent/AUPR743101A0/en
Priority to TW091100845A priority patent/TWI319011B/en
Priority to CN2009101328012A priority patent/CN101555283B/en
Priority to AT08156593T priority patent/ATE548383T1/en
Priority to CNB028050789A priority patent/CN100497385C/en
Priority to AT02715313T priority patent/ATE418565T1/en
Priority to DK02715313T priority patent/DK1360203T3/en
Priority to DE60230482T priority patent/DE60230482D1/en
Priority to JP2002558379A priority patent/JP4384852B2/en
Priority to PCT/AU2002/000061 priority patent/WO2002057306A1/en
Priority to ES08156593T priority patent/ES2383712T3/en
Priority to EP02715313A priority patent/EP1360203B1/en
Priority to EP08156593A priority patent/EP1961767B1/en
Priority to CA2434490A priority patent/CA2434490C/en
Priority to ES02715313T priority patent/ES2320421T3/en
Priority to DK08156593.9T priority patent/DK1961767T3/en
Priority to MYPI20020182A priority patent/MY158262A/en
Priority to PT02715313T priority patent/PT1360203E/en
Priority to CA2459348A priority patent/CA2459348C/en
Priority to NZ565994A priority patent/NZ565994A/en
Priority to CNB028214331A priority patent/CN100497386C/en
Priority to JP2003525032A priority patent/JP4467973B2/en
Priority to AU2002322192A priority patent/AU2002322192B2/en
Priority to NZ549019A priority patent/NZ549019A/en
Priority to TW091120122A priority patent/TWI329648B/en
Priority to CN2008102142942A priority patent/CN101445555B/en
Priority to PCT/AU2002/001204 priority patent/WO2003020762A1/en
Priority to MYPI20023310A priority patent/MY142283A/en
Priority to US10/622,313 priority patent/US7326415B2/en
Priority to AU2003235005A priority patent/AU2003235005B2/en
Priority to ZA2004/02630A priority patent/ZA200402630B/en
Priority to HK05103553.8A priority patent/HK1070903A1/en
Priority to US11/968,607 priority patent/US7531171B2/en
Priority to HK09101899.1A priority patent/HK1123311A1/en
Priority to US12/417,989 priority patent/US7888473B2/en
Priority to JP2009112881A priority patent/JP4457169B2/en
Priority to HK10103195.5A priority patent/HK1138013A1/en
Priority to US12/975,341 priority patent/US8080635B2/en
Priority to US13/298,222 priority patent/US8399617B2/en
Priority to US13/766,630 priority patent/US8709425B2/en
Priority to US14/218,935 priority patent/US20140323693A1/en
Priority to US14/726,391 priority patent/US9663584B2/en
Priority to US15/498,301 priority patent/US10450380B2/en
Priority to US16/568,072 priority patent/US20200071419A1/en
Abandoned legal-status Critical Current

Links

AUPR7431A 2001-01-17 2001-09-03 A cancer therapeutic Abandoned AUPR743101A0 (en)

Priority Applications (44)

Application Number Priority Date Filing Date Title
AUPR7431A AUPR743101A0 (en) 2001-09-03 2001-09-03 A cancer therapeutic
PT02715313T PT1360203E (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
JP2002558379A JP4384852B2 (en) 2001-01-17 2002-01-17 Non-functional P2X7 receptor antibody, diagnosis and treatment of cancer and other conditions
ES08156593T ES2383712T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
AT08156593T ATE548383T1 (en) 2001-01-17 2002-01-17 DIAGNOSIS AND TREATMENT OF CARCINOMA AND OTHER CONDITIONS
CNB028050789A CN100497385C (en) 2001-01-17 2002-01-17 Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome
AT02715313T ATE418565T1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2 X 7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER CONDITIONS
DK02715313T DK1360203T3 (en) 2001-01-17 2002-01-17 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancer disorders and other conditions
DE60230482T DE60230482D1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2X7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER SUFFERING
TW091100845A TWI319011B (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
PCT/AU2002/000061 WO2002057306A1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
CN2009101328012A CN101555283B (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
EP02715313A EP1360203B1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
EP08156593A EP1961767B1 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
CA2434490A CA2434490C (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
ES02715313T ES2320421T3 (en) 2001-01-17 2002-01-17 ANTIBODIES FOR THE DIAGNOSIS OF A NON-FUNCTIONAL P2X7 RECEIVER AND THE TREATMENT OF CANCER AND OTHER AFFECTIONS.
DK08156593.9T DK1961767T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other disorders
MYPI20020182A MY158262A (en) 2001-01-17 2002-01-17 Diagnosis and treatments of cancers and other conditions
CN2008102142942A CN101445555B (en) 2001-09-03 2002-09-03 Non-functional P2X7receptor antibodies, diagnosis and treatment of cancer and other diseases
CNB028214331A CN100497386C (en) 2001-09-03 2002-09-03 Antibodies of non-functional P2X7 receptor and its uses
PCT/AU2002/001204 WO2003020762A1 (en) 2001-09-03 2002-09-03 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
CA2459348A CA2459348C (en) 2001-09-03 2002-09-03 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
JP2003525032A JP4467973B2 (en) 2001-09-03 2002-09-03 Diagnosis and treatment of antibodies, cancer and other symptoms corresponding to non-functional P2X7 receptor
AU2002322192A AU2002322192B2 (en) 2001-09-03 2002-09-03 Antibodies to non-functional P2X7receptor, diagnosis and treatment of cancers and other conditions
NZ549019A NZ549019A (en) 2001-09-03 2002-09-03 Antibody that binds to a P2X7 receptor in which proline at position 210 is in a cis conformation
TW091120122A TWI329648B (en) 2001-09-03 2002-09-03 Diagnosis and treatment of cancers and other conditions
NZ565994A NZ565994A (en) 2001-09-03 2002-09-03 Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions
MYPI20023310A MY142283A (en) 2001-09-03 2002-09-04 Diagnosis and treatment of cancers and other conditions
US10/622,313 US7326415B2 (en) 2001-01-17 2003-07-17 Antibodies to non-functional P2X7 receptor
AU2003235005A AU2003235005B2 (en) 2001-01-17 2003-08-14 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions
ZA2004/02630A ZA200402630B (en) 2001-09-03 2004-04-02 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
HK05103553.8A HK1070903A1 (en) 2001-01-17 2005-04-26 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US11/968,607 US7531171B2 (en) 2001-01-17 2008-01-02 Antibodies to non-functional P2X7 receptor
HK09101899.1A HK1123311A1 (en) 2001-01-17 2009-02-27 Diagnosis and treatment of cancers and other conditions
US12/417,989 US7888473B2 (en) 2001-01-17 2009-04-03 Non-functional P2X7 receptor
JP2009112881A JP4457169B2 (en) 2001-01-17 2009-05-07 Diagnosis and treatment of non-functional P2X7 receptor antibodies, cancer and other conditions
HK10103195.5A HK1138013A1 (en) 2001-01-17 2010-03-29 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US12/975,341 US8080635B2 (en) 2001-01-17 2010-12-21 Non-functional P2X7 receptor
US13/298,222 US8399617B2 (en) 2001-01-17 2011-11-16 Non-functional P2X7 receptor
US13/766,630 US8709425B2 (en) 2001-01-17 2013-02-13 Antibodies to non-functional P2X7 receptor
US14/218,935 US20140323693A1 (en) 2001-01-17 2014-03-18 Antibodies To Non-Functional P2X7 Receptor
US14/726,391 US9663584B2 (en) 2001-01-17 2015-05-29 Antibodies to non-functional P2X7 receptor
US15/498,301 US10450380B2 (en) 2001-01-17 2017-04-26 Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor
US16/568,072 US20200071419A1 (en) 2001-01-17 2019-09-11 Antibodies to non-functional p2x7 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR7431A AUPR743101A0 (en) 2001-09-03 2001-09-03 A cancer therapeutic

Publications (1)

Publication Number Publication Date
AUPR743101A0 true AUPR743101A0 (en) 2001-09-27

Family

ID=3831382

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR7431A Abandoned AUPR743101A0 (en) 2001-01-17 2001-09-03 A cancer therapeutic

Country Status (1)

Country Link
AU (1) AUPR743101A0 (en)

Similar Documents

Publication Publication Date Title
AU2002253490A1 (en) A catheter
AUPS054702A0 (en) Cancer therapy
AU2002365120A1 (en) Medicaments
WO2002089880A8 (en) Inhalers
AU2002222853A1 (en) Therapeutic compounds
AU2002253039A1 (en) Tramadol-based medicament
AU2002353739A1 (en) Therapeutic compounds
AUPR320701A0 (en) The new cancer therapeutic agent with a thiopeptides
AU2002335667A1 (en) Modified reoviral therapy
AU2002331816A1 (en) A cancer treatment system
AU2001257325A1 (en) Cancer treatment
AU2003283339A1 (en) Cancer therapy determination
AU2002351382A1 (en) Combination cancer therapy
AUPR743101A0 (en) A cancer therapeutic
AU2002357046A1 (en) Combination therapy comprising a cyclooygenase-2 inhibitor
AU2001292897A1 (en) Novel therapy
AU2001257168A1 (en) Cancer treatment
AUPR969801A0 (en) Therapeutic compounds - ii
AU2002310189A1 (en) Tumor therapy
AU2002332636A1 (en) Wild-type ras as a cancer therapeutic agent
AUPR964001A0 (en) Therapeutic compounds
AUPR693801A0 (en) Therapeutic compounds
AUPR817901A0 (en) Therapeutic compounds
AU2002327598A1 (en) Methionine restriction for cancer therapy
AU2002345310A1 (en) A catheter